Order Article Reprints

Sharaf B, Al-Rwashdeh M, El Khatib O, Al-Ibraheem A, Abu Fara A, Ismail A, Alkasrawi H, Abdalla M, Jehad S. Treatment Sequencing in ARPI-Pre-Exposed Metastatic Castration-Resistant Prostate Cancer: Radioligand Therapy, PARP Inhibitors, and Antibody–Drug Conjugates. Cancers. 2026; 18(19):3119. https://doi.org/10.3390/cancers18193119

Sharaf, Baha, Mohammad Al-Rwashdeh, Osama El Khatib, Akram Al-Ibraheem, Ala Abu Fara, Ameen Ismail, Hadeel Alkasrawi, Mohamed Abdalla, and Sharif Jehad. 2026. "Treatment Sequencing in ARPI-Pre-Exposed Metastatic Castration-Resistant Prostate Cancer: Radioligand Therapy, PARP Inhibitors, and Antibody–Drug Conjugates" Cancers 18, no. 19: 3119. https://doi.org/10.3390/cancers18193119

Sharaf, B., Al-Rwashdeh, M., El Khatib, O., Al-Ibraheem, A., Abu Fara, A., Ismail, A., Alkasrawi, H., Abdalla, M., & Jehad, S. (2026). Treatment Sequencing in ARPI-Pre-Exposed Metastatic Castration-Resistant Prostate Cancer: Radioligand Therapy, PARP Inhibitors, and Antibody–Drug Conjugates. Cancers, 18(19), 3119. https://doi.org/10.3390/cancers18193119